Advantages and disadvantages of pain therapies
Intervention | Advantages | Disadvantages |
---|---|---|
Oral analgesics Acetaminophen Aspirin NSAIDs |
1. Useful for a wide variety of mild to moderate pains. | 1. Ceiling effect to analgesia. |
2. Widely available, some over the counter. | 2. Side effects, especially gastritis and renal toxicity, can be serious. | |
3. Additive analgesia when combined with opioids and other modalities. | 3. May risk bleeding in severely thrombocytopenic patients. | |
4. Can be administered by patient or family. | 4. Only one NSAID (ketorolac) is available now for parenteral administration | |
5. Some are inexpensive. | 5. Many are expensive. | |
Oral opioids | 1. Effective for both localized and generalized pain. | 1. Side effects may limit analgesic effectiveness. |
2. Ceiling to analgesic effectiveness imposed only by side effects. | 2. Prescription of these substances is regulated. | |
3. Multiple drugs choices in this class. | 3. Stigma or fears associated with use. | |
4. Sedative and anxiolytic properties useful in some acute treatment settings. | ||
5. Can be administered by patient or family. | ||
6. Some are inexpensive. | ||
7. Long acting, controlled-release forms available. | ||
Transdermal opioids(fentanyl) | 1. Long duration of action (48 - 72 hours) from single patch. | 1. Side effects may not be as quickly as in oral opioid administration. |
2. Allows use of a strong opioid (fentanyl) in outpatient settings for some patients who have not tolerated morphin and related drugs. | 2. Difficult to modify dosage rapidly. | |
3. Many patients find them easy to use. | 3. Relatively slow onset of action. | |
4. Provides continuous administration of an opioid without use of needles or pumps. | 4. Requires additional short-acting medicine for breakthrough pain. | |
5. Can be administered by patient or family. | 5. Expensive. | |
Rectal opioids | 1. Relatively easy-to-use alternative route when the oral route is unavailable. | 1. Not widely accepted by patients or families. |
2. Other opioid suppositories available for morphine intolerant patients. | 2. Side effects may limit analgesic effectiveness. | |
3. Can be administered by patient or family. | 3. Relatively slow onset of action. | |
4. Less expensive than subcutaneous or intravenous infusions. | 4. Contraindicated if low white blood cell or platelet count (risks of infection, bleeding). | |
Subcutaneous infusion | 1. Can provide rapid pain relief without intravenous access. | 1. Only a limited volume infusate can be administered (e.g. 2 to 4 ml/hour). |
2. Morphine or hydromorphone are the preferred drugs for this route when administered in the home. | 2. Induration, irritation at infusion site may be a complication. | |
3. When used in PCA mode, allows for rapid individual dose titration and provides sense of control for patient. | 3. Requires skilled nursing and pharmacy support. | |
4. Often requires expensive drug infusion pump and recurring charges for disposables. | ||
Intravenous infusion | 1. Can provide rapid pain relief. | 1. Infection and infiltration of intravenous lines are potential complications. |
2. Almost all opioids can be given by this route. | 2. Requires skilled nursing and pharmacy support. | |
3. Not limited by infusate volumes. | 3. Often requires expensive drug infusion pump and recurring charges for disposables. | |
4. When used in PCA mode, allows for rapid individual dose titration and provides sense of control for patient. | ||
Epidural, intrathecal, and intracerebral ventricular routes | 1. Useful for pain that has not responded to less invasive measures. | 1. Tolerance may occur sooner than with oral or rectal administration. |
2. Local anesthetics may be added to spinal opioids and may produce additive analgesia. | 2. Infection at catheter site can produce meningitis and/or epidural abscess. | |
3. Pruritus and urinary retention are more common than with oral or parenteral opioid administration. | ||
4. Contraindicated in presence of acute spinal cord compression. | ||
5. Requires special expertise. | ||
6. Requires careful monitoring, especially when therapy begins and when doses are increased. | ||
7. May require expensive drug infusion pump, intervention fees, and recurring charges for disposables. | ||
Regional neurolytic blocks | 1. Effective for pain relief with certain diagnoses (e.g pancreatic cancer). | 1. Risk of postural hypotension, bowel and bladder incontinence, and leg weakness. |
2. May be useful for movement-related and abdominal visceral pain that is refractory to drug therapy. | 2. Procedure is irreversible. | |
3. Can allow dosage (and side effect) reduction of systemic drugs for localized pain. | 3. Requires special expertise. | |
4. Expenses for specialized care and operating room costs. | ||
Ablative neurosurgery | 1. May be useful for movement-related lower body pain that is refractory to drug therapy. | 1. Six-month duration of pain relief for cordotomy is only 50%. |
2. Fast onset of pain relief. | 2. Procedure is irreversible. | |
3. Percutaneous cordotomy can be done under local anesthesia. | 3. Requires special expertise. | |
4. Can allow dosage (and side effect) reduction of systemic drugs for localized pain. | 4. Expensive because of specialized care and operating room costs. | |
Corticosteroids | 1. Effective in pain associated with inflammatory component (e.g., bone pain). | 1. Prolonged use associated with adrenal suppression, fluid and electrolyte disturbance. |
2. Can produce cytotoxic effect against some tumors. | 2. Increases risk of gastritis. | |
3. May be given orally or intravenously. | 3. Prolonged use may decrease cell-mediated immunity and increase risk of infection. | |
4. May increase appetite. | 4. Some patients experience emotional instability or psychoses. | |
5. May produce euphoria in some patients. | 5. May suppress (mask) fevers associated with | |
6. May decrease pain associated with CNS and spinal cord tumors. | ||
Anticonvulsants | 1. Useful for peripheral pain syndromes associated withneuropathic pain, especially lancinating or shooting pain. | 1. May increase sedation. |
2. Monitoring required to avoid specific toxicities associated with increased serum levels. | ||
3. Idiosyncratic or dose-related bone marrow suppression may limit usefulness. | ||
Antidepressants | 1. Useful in pain syndromes associated with neuropathic pain and with pain caused by surgery, chemotherapy, or nerve infiltration. | 1. May increase sedation. |
2. May promote sleep when taken at bedtime. | 2. Anticholinergic side effects of many antidepressants are distressing to many patients. | |
3. CNS, cardiovascular, and hepatic toxicities may limit usefulness. | ||
Hydroxyzine | 1. When given in high dosages (100 mg), some antihistamines may produce additive analgesia with therapeutic doses of opioids. | 1. In high doses demonstrates a significant potential for causing respiratory depression which is additive to that of opioids, but not reversible with naloxone. |
2. May be beneficial in patients with opioid-induced nausea and vomiting. | 2. Can cause significant sedation. | |
Radiation therapy | 1. Directly treats tumor, especially useful for bone metastasis. | 1. When multiple fractions are given, it may produce prolonged inconvenience and discomfort for patients. |
2. Can provide fast onset of pain relief. | 2. Myelosuppression may occur, especially with prior chemotherapy when wide teletherapy or radiopharmaceuticals are used. | |
3. Single dose is effective for some patients. | ||
4. Widely available mode of treatment. | ||
5. Radiopharmaceuticals and some forms of radiation therapy can treat multiple disease sites. | ||
Relaxation, imagery, biofeedback, distraction, and reframing | 1. May decrease pain and anxiety without drug-related side effects. | 1. Patient must be motivated to use self-management strategies. |
2. Can be used as adjuvant therapy with most other modalities. | 2. Requires professional time to teach interventions. | |
3. Can increase patient's sense of control. | ||
4. Most are inexpensive, require no special equipment, and are easily administered. | ||
Patient education | 1. Effective in improving ability to follow medical regimen and in decreasing pain. | 1. Requires professional time to teach pain management regimens. |
2. Multiple teaching aids available. | ||
3. Promotes self-care in pain treatment and management of side effects. | ||
Psychotherapy, structured support, and hypnosis | 1. May decrease pain and anxiety for patients who have pain that is difficult to manage. | 1. Requires skilled therapist. |
2. May increase patient's coping skills. | ||
Cutaneous stimulation (superficial heat, cold, and massage) | 1. May reduce pain, inflammation, and/or muscle spasm. | 1. Heat may increase bleeding and edema after acute injury. |
2. Can be used as adjuvant therapy with most other modalities. | 2. Cold is contraindicated for use over ischemic tissues. | |
3. Relatively easy to use. | ||
4. Can be administered by patients or families. | ||
5. Relatively low cost. | ||
Transcutaneous electrical nerve stimulation | 1. May provide pain relief without drug-related side effects. | 1. Requires skilled therapist to initiate therapy. |
2. Can be used as adjuvant therapy with most other modalities. | 2. Potential risk of infection, bleeding. | |
3. Gives patient sense of control over pain. | ||
Acupuncture | 1. May provide pain relief without side effects. | 1. Requires skilled therapist. |
2. Can be used as adjuvant with most other therapies. | ||
Peer support groups | 1. May increase patient's coping skills. | 1. None identified. |
2. Increases sense of control. | ||
3. Provides support for families and patients. | ||
Pastoral counseling | 1. May increase patient's coping skills. | 1. None identified |
2. May provide spiritual and emotional comfort |
Go to the Pain & HIV/AIDS Menu
Go to the HIVpositive.us Main Menu
74